Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Pediatr Blood Cancer. 2017 May 18;64(12):10.1002/pbc.26645. doi: 10.1002/pbc.26645

TABLE 3.

Distribution by Oberlin risk score for ARMS cases with known fusion status and presumed fusion negative ERMS (D9802 and ARST0431)

Total
Fusion positive
Fusion negative
Risk score N (%) 5-Year EFS
(95% CI)
N (%) 5-Year EFS
(95% CI)
N (%)
(ARMSn/ERMS)
5-Year EFS
(95% CI)
Long-rank
P value
0,1 42 (32%) 9(21%) 33 (79%)

52.4(17–87.8) 27.8 (0–60.5) (4/29) 58.5 (21.6–95.4) 0.07

2 35 (27%) 23 (66%) 12 (34%)

22.8 (3.2–42.5) 15.8 (0–32.3) (2/10) 41.7(10.5–72.9) 0.42

3 35 (27%) 24 (69%) 11 (31%)

6.3 (0–18.2) 4.7 (0–13.8) (4/7) 9.1(0–26.1) 0.70

4 18 (14%) 12 (67%) 6 (33%)

0 0 (2/4) 0 0.72

EFS, event-free survival.